Assobiotec

News

10 February 2020

The Jenner Institute signs an agreement with Advent to develop a novel coronavirus vaccine

The Jenner Institute, Oxford University, UK and Advent Srl – an IRBM company, Pomezia,Italy – are continuing their long-standing history of collaboration, by announcing a new agreement to develop a novel vaccine for coronavirus.
  Read more
04 February 2020

Takis and Evvivax developing a 2019-nCoV Coronavirus vaccine

Takis and Evvivax, two biotechnology companies present in the science park of Castel Romano, Rome announce their commitment for the development of innovative vaccines against 2019-nCoV
  Read more
14 January 2020

Axxam and ZoBio form a strategic alliance integrating their Drug Discovery Services Platforms

Axxam and ZoBio announced a strategic alliance to provide a combination of integrated discovery services spanning all phases from gene to fully optimized leads
  Read more
16 December 2019

Takis second Biotech in Europe at EIT Health Catapult Final!

NeoMatrix, a neoantigen-based cancer vaccine based on Precision Immunology has been awarded second among the best Biotech companies in Europe. The journey started this summer, when a though selection of 150 companies led to a list of 7 finalists.
  Read more
06 November 2019

Newron Initiates Outreach on First Global Rett Syndrome Burden of Illness Survey in Collaboration with the Rett Community

The results of the survey will help identify and guide improved intervention programs and services designed to complement the Rett care pathway.
  Read more
24 October 2019

Intrepida Bio uncloaks with $9.5M and anti-BAG3 cancer programs from Italy

Biouniversa creates a strategic partnership with two important American funds, creating a new company in California
  Read more
1 2 3 4 5  ... 

Where to find us

20149 Milan
Via Giovanni da Procida, 11
Show map 
Tel. +39 02.34565.1
Fax. +39 02.34565.310
Segreteria Assobiotec
Tel. 02 34565.256/341
assobiotec@federchimica.it